Dr Reddys Laboratories (RDY) Ending Cash Balance (2009 - 2026)
Dr Reddys Laboratories (RDY) reported Ending Cash Balance of $137.32 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), up 23.0% from $111.67 million a year earlier but down 15.3% from the prior quarter.
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Ending Cash Balance (2009 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Dr Reddys Laboratories posted Ending Cash Balance of $164 million, up 5.1% from FY2025.
- Ending Cash Balance has increased for three consecutive fiscal years, though with a five-year compound annual growth rate of -3.4% (FY2021 to FY2026).
- By fiscal year, Ending Cash Balance came in at $156 million in FY2025 (+83.5%), $85 million in FY2024 (+23.2%), $69 million in FY2023 (-61.9%) and $181 million in FY2022 (-7.2%).
- Five-year quarterly Ending Cash Balance spans a low of $58.87 million in fiscal Q1 2025 and a high of $295.25 million in fiscal Q3 2022.
- Year over year, Ending Cash Balance gained in three of the last six quarters, with growth averaging 47.7%.
- The high point for year-over-year Ending Cash Balance in five years was fiscal Q3 2022 (growth of 399.7%); the low point was fiscal Q3 2023 (a decline of 74.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Ending Cash Balance (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 1.88 Bn |
| 10 | Dr Reddys Laboratories | 12.40 Bn | 11.74 Bn | 472.93 Mn | 137.32 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 137.32 Mn |
| Jun 30, 2026 | 162.13 Mn |
| Mar 31, 2026 | 162.87 Mn |
| Sep 30, 2025 | 111.67 Mn |
| Jun 30, 2025 | 170.77 Mn |
| Mar 31, 2025 | 170.60 Mn |
| Sep 30, 2024 | 134.80 Mn |
| Jun 30, 2024 | 58.87 Mn |
| Mar 31, 2024 | 85.22 Mn |
| Dec 31, 2023 | 91.55 Mn |
| Sep 30, 2023 | 162.69 Mn |
| Jun 30, 2023 | 88.07 Mn |
| Mar 31, 2023 | 70.39 Mn |
| Dec 31, 2022 | 75.56 Mn |
| Sep 30, 2022 | 111.60 Mn |
| Jun 30, 2022 | 79.81 Mn |
| Mar 31, 2022 | 195.86 Mn |
| Dec 31, 2021 | 295.25 Mn |
| Sep 30, 2021 | 134.28 Mn |
| Jun 30, 2021 | 109.95 Mn |
API Access
Dr Reddys Laboratories Ending Cash Balance API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ending-cash-balance", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();